{"rows":[{"id":4178,"title":"Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin","normalized_title":"symptom level antidepressant response to psilocybin exploratory outcomes comparing psilocybin treatment to niacin","authors":"E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2026.106904","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2026.106904","keywords":"Medicine, Antidepressant, Niacin, Psilocybin, Pharmacology, Mirtazapine, Internal medicine, Psychiatry, Clinical trial, MEDLINE, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Pain Management and Placebo Effect","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7161898772\",\"openalex_url\":\"https://openalex.org/W7161898772\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5136584767\",\"display_name\":\"E. Lopez\",\"orcid\":null},{\"id\":\"https://openalex.org/A5125067605\",\"display_name\":\"J O Lundberg\",\"orcid\":null},{\"id\":\"https://openalex.org/A5082700012\",\"display_name\":\"F. Hieronymus\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136592297\",\"display_name\":\"M. Beckman\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136572678\",\"display_name\":\"H. Yngwe\",\"orcid\":null},{\"id\":\"https://openalex.org/A5011966942\",\"display_name\":\"C.J. Ekman\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121794244\",\"display_name\":\"M. Tiger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136580362\",\"display_name\":\"N. Edvall\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106904\",\"is_oa\":true}}","topic_tags":"Chronic Pain,Pharmacology,Clinical Trial,Toxicity","study_type":"Clinical Trial","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7161898772"},{"id":4177,"title":"Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study","normalized_title":"self reported benefits and harms of microdosing with natural psilocybin preliminary results from a naturalistic study","authors":"I. Totomanova, E.C.H.M. Haijen, P.P.M. Hurks, NL Mason, JG Ramaekers, K.P.C. Kuypers","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2026.106942","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2026.106942","keywords":"Natural (archaeology), Psychology, Social psychology, Naturalistic observation, Action (physics), Agency (philosophy), Naturalism, Applied psychology, Environmental health, Behaviour change, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Pain Management and Placebo Effect","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7161827243\",\"openalex_url\":\"https://openalex.org/W7161827243\",\"openalex_relevance_score\":4,\"openalex_relevance_reasons\":[\"title:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121833055\",\"display_name\":\"I. Totomanova\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121779284\",\"display_name\":\"E.C.H.M. Haijen\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136595014\",\"display_name\":\"P.P.M. Hurks\",\"orcid\":null},{\"id\":\"https://openalex.org/A5110749453\",\"display_name\":\"NL Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5103425123\",\"display_name\":\"JG Ramaekers\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121765730\",\"display_name\":\"K.P.C. Kuypers\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106942\",\"is_oa\":true}}","topic_tags":"Chronic Pain,Microdosing","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7161827243"},{"id":4176,"title":"Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults","normalized_title":"dynamic response of intrinsic connectivity networks to low dose psilocybin during face matching in autistic adults","authors":"Y. Ge, T.P. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, F.M. Ponteduro, N. Khalil, S. Fenn-Moltu, NA Puts, E. Daly, D.G.M. Murphy, G.M. McAlonan, D. Batalle","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2026.106906","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2026.106906","keywords":"Psilocybin, Psychology, Face (sociological concept), Matching (statistics), Computer science, Neuroscience, Facial recognition system, Artificial intelligence, Cognitive psychology, Face perception, Autism, Functional connectivity, Property (philosophy), Communication, Computer vision, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Face Recognition and Perception","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7161826543\",\"openalex_url\":\"https://openalex.org/W7161826543\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5136536811\",\"display_name\":\"Y. Ge\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136531578\",\"display_name\":\"T.P. Whelan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121797325\",\"display_name\":\"M. Dimitrov\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799276\",\"display_name\":\"C.L. Ellis\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833749\",\"display_name\":\"F. Moruzzi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799145\",\"display_name\":\"J. Kangas\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136563571\",\"display_name\":\"F.M. Ponteduro\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759661\",\"display_name\":\"N. Khalil\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136536804\",\"display_name\":\"S. Fenn-Moltu\",\"orcid\":null},{\"id\":\"https://openalex.org/A5114081015\",\"display_name\":\"NA Puts\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136522615\",\"display_name\":\"E. Daly\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832208\",\"display_name\":\"D.G.M. Murphy\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121782292\",\"display_name\":\"G.M. McAlonan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136507347\",\"display_name\":\"D. Batalle\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106906\",\"is_oa\":true}}","topic_tags":"General","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7161826543"},{"id":4160,"title":"Electrical brain changes following psilocybin administration in sprague-dawley rats","normalized_title":"electrical brain changes following psilocybin administration in sprague dawley rats","authors":"B. Richardson, V. Bruno, J. O'Byrne, G. Gobbi","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106819","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106819","keywords":"Medicine, Pharmacology, Psilocybin, Central nervous system, Administration (probate law), Drug administration, Anesthesia, Neuroscience, Hallucinogen, Hippocampus, Action (physics), Drug, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118013054\",\"openalex_url\":\"https://openalex.org/W7118013054\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121759287\",\"display_name\":\"B. Richardson\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121787318\",\"display_name\":\"V. Bruno\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121802428\",\"display_name\":\"J. O'Byrne\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121772763\",\"display_name\":\"G. Gobbi\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106819\",\"is_oa\":true}}","topic_tags":"Pharmacology,Toxicity","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118013054"},{"id":4159,"title":"Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people","normalized_title":"low dose psilocybin differentially alters resting state network connectivity in autistic and non autistic people","authors":"T. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, N. Khalil, G. Ivin, E. Daly, NA Puts, D.G.M. Murphy, G.M. McAlonan","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.105782","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.105782","keywords":"Neuroscience, Psilocybin, Psychology, Schizophrenia (object-oriented programming), Medicine, Central nervous system, Nerve net, Computer science, Biology, Autism, Functional connectivity, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Forensic Toxicology and Drug Analysis","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118011913\",\"openalex_url\":\"https://openalex.org/W7118011913\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121800389\",\"display_name\":\"T. Whelan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121797325\",\"display_name\":\"M. Dimitrov\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799276\",\"display_name\":\"C.L. Ellis\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833749\",\"display_name\":\"F. Moruzzi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799145\",\"display_name\":\"J. Kangas\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759661\",\"display_name\":\"N. Khalil\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121828214\",\"display_name\":\"G. Ivin\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121831468\",\"display_name\":\"E. Daly\",\"orcid\":null},{\"id\":\"https://openalex.org/A5114081015\",\"display_name\":\"NA Puts\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832208\",\"display_name\":\"D.G.M. Murphy\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121782292\",\"display_name\":\"G.M. McAlonan\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105782\",\"is_oa\":true}}","topic_tags":"Toxicity","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118011913"},{"id":4158,"title":"Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial","normalized_title":"efficacy and safety of psilocybin in treatment resistant major depression episode results of a randomized active placebo controlled trial","authors":"L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.105779","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.105779","keywords":"Medicine, Depression (economics), Psilocybin, Randomized controlled trial, Internal medicine, Psychiatry, Major depressive disorder, Clinical trial, Treatment-resistant depression, Adverse effect, Anxiety, Placebo, Placebo response, Psychedelics and Drug Studies, Pain Management and Placebo Effect, Paranormal Experiences and Beliefs","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118005769\",\"openalex_url\":\"https://openalex.org/W7118005769\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121822190\",\"display_name\":\"L.J. Mertens\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121824543\",\"display_name\":\"M. Koslowski\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121783775\",\"display_name\":\"F. Betzler\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121792507\",\"display_name\":\"M. Brand\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121791537\",\"display_name\":\"R. Evens\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121810759\",\"display_name\":\"L. Krätner\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833521\",\"display_name\":\"A. Jungaberle\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121791366\",\"display_name\":\"H. Jungaberle\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121773388\",\"display_name\":\"T. Majić\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121822296\",\"display_name\":\"C.N. Schmitz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121811371\",\"display_name\":\"A. Ströhle\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121789885\",\"display_name\":\"D. Scharf\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121826605\",\"display_name\":\"M. Spangemacher\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121785997\",\"display_name\":\"M. Wolff\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121758999\",\"display_name\":\"Z. Assadi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121789441\",\"display_name\":\"B. Scharif\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121823024\",\"display_name\":\"L. Becher\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121824758\",\"display_name\":\"L.V. Färber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806858\",\"display_name\":\"N. Kirchen\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121800185\",\"display_name\":\"E. Kulakova\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759413\",\"display_name\":\"L. Kunz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121774631\",\"display_name\":\"A. Meijer\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121756009\",\"display_name\":\"B. Rohrmoser\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121827624\",\"display_name\":\"S. Wellek\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121760402\",\"display_name\":\"M. Berger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121772024\",\"display_name\":\"G. Gründer\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105779\",\"is_oa\":true}}","topic_tags":"Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118005769"},{"id":4157,"title":"The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial","normalized_title":"the impact of comp360 psilocybin on anhedonia post hoc analyses from a phase iib randomised controlled trial","authors":"L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106572","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106572","keywords":"Randomized controlled trial, Medicine, Psilocybin, Phase (matter), Pharmacology, Internal medicine, Anesthesia, Clinical trial, Placebo, MEDLINE, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118005328\",\"openalex_url\":\"https://openalex.org/W7118005328\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121821524\",\"display_name\":\"L. Marwood\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806415\",\"display_name\":\"M. Young\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121754295\",\"display_name\":\"J. Chai-Rees\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121778088\",\"display_name\":\"S. Mistry\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121801763\",\"display_name\":\"S. Maxwell\",\"orcid\":null},{\"id\":\"https://openalex.org/A5023164918\",\"display_name\":\"G.M. Goodwin\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106572\",\"is_oa\":true}}","topic_tags":"Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity","study_type":"Randomized Controlled Trial","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118005328"},{"id":4156,"title":"Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model","normalized_title":"psilocybin and ibogaine as therapeutic candidates for cocaine addiction insights from a rat self administration model","authors":"I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106393","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106393","keywords":"Psilocybin, Pharmacology, Medicine, Hallucinogen, Chemistry, Neuroscience, Drug, Riluzole, Animal model, Mephedrone, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Neurotransmitter Receptor Influence on Behavior","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7117971173\",\"openalex_url\":\"https://openalex.org/W7117971173\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121823805\",\"display_name\":\"I.R.A. Koutrouli\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121827695\",\"display_name\":\"K. Šíchová\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121813066\",\"display_name\":\"W. Kacper\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121754648\",\"display_name\":\"V. Brejtr\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121784252\",\"display_name\":\"K. Aleksič\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121769225\",\"display_name\":\"N. Miniariková\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121818721\",\"display_name\":\"E. Lhotková\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121752090\",\"display_name\":\"M. Nikolič\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832941\",\"display_name\":\"T. Páleníček\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106393\",\"is_oa\":true}}","topic_tags":"Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Toxicity","study_type":"Animal Study","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7117971173"},{"id":4155,"title":"An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes","normalized_title":"an open label study of single dose comp360 psilocybin for post traumatic stress disorder safety tolerability and secondary efficacy outcomes","authors":"N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106821","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106821","keywords":"Medicine, Stress (linguistics), Psilocybin, Internal medicine, Depression (economics), Fight-or-flight response, Clinical trial, Disease, Pharmacology, Placebo, Psychedelics and Drug Studies, Pain Management and Placebo Effect, Digital Mental Health Interventions","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7117964120\",\"openalex_url\":\"https://openalex.org/W7117964120\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121770090\",\"display_name\":\"N. Mcgowan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121788394\",\"display_name\":\"J. Rucker\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121776293\",\"display_name\":\"R. Yehuda\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806605\",\"display_name\":\"M. Agrawal\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121802584\",\"display_name\":\"H. Simmons\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121797777\",\"display_name\":\"S. Das\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121813176\",\"display_name\":\"G. Goodwin\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106821\",\"is_oa\":true}}","topic_tags":"Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety","study_type":"Clinical Trial","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7117964120"},{"id":4153,"title":"Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression","normalized_title":"relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment resistant depression","authors":"L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106390","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106390","keywords":"Psilocybin, Depression (economics), Medicine, Psychiatry, Hallucinogen, Psychology, Clinical psychology, Anxiety, Disease, Affect (linguistics), Cognition, Psychedelics and Drug Studies, Pain Management and Placebo Effect, Forensic Toxicology and Drug Analysis","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:37","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7117961846\",\"openalex_url\":\"https://openalex.org/W7117961846\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121762326\",\"display_name\":\"L. Puhl\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759413\",\"display_name\":\"L. Kunz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121760402\",\"display_name\":\"M. Berger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121772024\",\"display_name\":\"G. Gründer\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121809489\",\"display_name\":\"L. Mertens\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121826605\",\"display_name\":\"M. Spangemacher\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106390\",\"is_oa\":true}}","topic_tags":"Depression,Anxiety,Chronic Pain,Treatment-Resistant Depression,Toxicity","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7117961846"},{"id":2001,"title":"Preclinical evaluation of psilocybin as an anti-inflammatory agent","normalized_title":"preclinical evaluation of psilocybin as an anti inflammatory agent","authors":"N. Martínez-Álvarez, I. Erkizia-Santamaría, A. Tomás-Alvarado, A.M. Erdozain, J.J. Meana, J.E. Ortega","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.105853","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.105853","keywords":"Psilocybin, Medicine, Pharmacology, Neuroscience, Drug, Hallucinogen, Riluzole, Chemistry, Disease, Computer science, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Pain Management and Placebo Effect","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-01 06:52:05","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118009135\",\"openalex_url\":\"https://openalex.org/W7118009135\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121773140\",\"display_name\":\"N. Martínez-Álvarez\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121779293\",\"display_name\":\"I. Erkizia-Santamaría\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121780610\",\"display_name\":\"A. Tomás-Alvarado\",\"orcid\":null},{\"id\":\"https://openalex.org/A5030341011\",\"display_name\":\"A.M. Erdozain\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121834541\",\"display_name\":\"J.J. Meana\",\"orcid\":null},{\"id\":\"https://openalex.org/A5105369889\",\"display_name\":\"J.E. Ortega\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105853\",\"is_oa\":true}}","topic_tags":"Chronic Pain,Pharmacology,Animal Study,Toxicity,Inflammation","study_type":"Animal Study","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118009135"},{"id":2000,"title":"Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music","normalized_title":"psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music","authors":"M. Benes, D. Gregus, P. Adamek, T. Páleníček, J. Horacek","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106823","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106823","keywords":"Psychology, Active listening, Psilocybin, Cognitive psychology, Developmental psychology, Social psychology, Cognition, Communication, Affect (linguistics), Audiology, Psychedelics and Drug Studies, Nicotinic Acetylcholine Receptors Study, Cannabis and Cannabinoid Research","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-01 06:52:05","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118007847\",\"openalex_url\":\"https://openalex.org/W7118007847\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121820960\",\"display_name\":\"M. Benes\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121754529\",\"display_name\":\"D. Gregus\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121829256\",\"display_name\":\"P. Adamek\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832941\",\"display_name\":\"T. Páleníček\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121831014\",\"display_name\":\"J. Horacek\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106823\",\"is_oa\":true}}","topic_tags":"Receptor Pharmacology,Healthy Volunteers","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118007847"},{"id":1998,"title":"Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults","normalized_title":"effects of low dose psilocybin on eeg markers of sensory processing in autistic and non autistic adults","authors":"O. Ollari, T.P. Whelan, C.L. Ellis, N. Khalil, F. Moruzzi, D.G.M. Murphy, E. Daly, L. Mason, N. Puts, G.M. McAlonan","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2026.106903","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2026.106903","keywords":"Psilocybin, Electroencephalography, Neuroscience, Sensory processing, Medicine, Sensory system, Audiology, Psychology, Schizophrenia (object-oriented programming), Electrophysiology, Neural activity, Hallucinogen, Neurophysiology, Cognition, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Pain Management and Placebo Effect","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-01 06:52:05","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7161753513\",\"openalex_url\":\"https://openalex.org/W7161753513\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5136578997\",\"display_name\":\"O. Ollari\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136531578\",\"display_name\":\"T.P. Whelan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799276\",\"display_name\":\"C.L. Ellis\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759661\",\"display_name\":\"N. Khalil\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833749\",\"display_name\":\"F. Moruzzi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832208\",\"display_name\":\"D.G.M. Murphy\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136522615\",\"display_name\":\"E. Daly\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136562256\",\"display_name\":\"L. Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5129790138\",\"display_name\":\"N. Puts\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121782292\",\"display_name\":\"G.M. McAlonan\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106903\",\"is_oa\":true}}","topic_tags":"Chronic Pain,Brain Imaging,Biomarkers","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7161753513"},{"id":1997,"title":"Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice","normalized_title":"mismatch between psilocybin induced head twitch behaviour and psilocin brain levels in mice","authors":"F. Sellitti, C. Weber, É. Tamura, Z. Li, J. Thomann, D. Luethi, L.D. Simmler","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106574","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106574","keywords":"Chemistry, Central nervous system, Biology, Neuroscience, Molecular biology, Cell biology, Nervous system, Biochemistry, Immune system, Component (thermodynamics), Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs","substance_tags":"psilocybin,psilocin","source_name":"OpenAlex","date_added":"2026-07-01 06:52:05","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118009596\",\"openalex_url\":\"https://openalex.org/W7118009596\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"title:psilocin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121758920\",\"display_name\":\"F. Sellitti\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121817927\",\"display_name\":\"C. Weber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121778565\",\"display_name\":\"É. Tamura\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121777883\",\"display_name\":\"Z. Li\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121827508\",\"display_name\":\"J. Thomann\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121809251\",\"display_name\":\"D. Luethi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121763859\",\"display_name\":\"L.D. Simmler\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106574\",\"is_oa\":true}}","topic_tags":"Animal Study,Toxicity,Immune Function","study_type":"Animal Study","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118009596"},{"id":1996,"title":"Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin","normalized_title":"preliminary results from an ongoing naturalistic survey study investigating dose finding practices and effects of self administered small amounts of psilocybin","authors":"I. Totomanova, E.C.H.M. Haijen, Petra P. M. Hurks, NL Mason, K.P.C. Kuypers","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106822","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106822","keywords":"Psilocybin, Psychology, Survey research, Naturalistic observation, Data collection, Applied psychology, Clinical psychology, Spouse, Social psychology, Affect (linguistics), Empirical research, Survey data collection, Naturalism, Research methodology, Research design, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-01 06:52:05","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7117971009\",\"openalex_url\":\"https://openalex.org/W7117971009\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121833055\",\"display_name\":\"I. Totomanova\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121779284\",\"display_name\":\"E.C.H.M. Haijen\",\"orcid\":null},{\"id\":\"https://openalex.org/A5074444381\",\"display_name\":\"Petra P. M. Hurks\",\"orcid\":\"https://orcid.org/0000-0002-4366-3707\"},{\"id\":\"https://openalex.org/A5110749453\",\"display_name\":\"NL Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121765730\",\"display_name\":\"K.P.C. Kuypers\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106822\",\"is_oa\":true}}","topic_tags":"Observational Study,Toxicity","study_type":"Observational Study","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7117971009"},{"id":1995,"title":"Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans","normalized_title":"temporal effects of a single oral dose of psilocybin on plasma circulating mirnas in humans","authors":"A. O'shea, JG Ramaekers, R. Schreiber, J.J. Briedé, J. Krauskopf, N. Mason, M.C.T. Verheijen","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106576","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106576","keywords":"Psilocybin, Medicine, Pharmacology, microRNA, Internal medicine, Endocrinology, Chemistry, Drug, Pharmacokinetics, Plasma concentration, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-01 06:52:05","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7117995674\",\"openalex_url\":\"https://openalex.org/W7117995674\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121784560\",\"display_name\":\"A. O'shea\",\"orcid\":null},{\"id\":\"https://openalex.org/A5103425123\",\"display_name\":\"JG Ramaekers\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806731\",\"display_name\":\"R. Schreiber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121785178\",\"display_name\":\"J.J. Briedé\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121770613\",\"display_name\":\"J. Krauskopf\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121821037\",\"display_name\":\"N. Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121795820\",\"display_name\":\"M.C.T. Verheijen\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106576\",\"is_oa\":true}}","topic_tags":"Pharmacology,Toxicity","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7117995674"},{"id":1994,"title":"Behavioral and neuronal effects of psilocybin in mice","normalized_title":"behavioral and neuronal effects of psilocybin in mice","authors":"C. Weber, F. Sellitti, L. Ziming, J. von Arx, L.D. Simmler","abstract":"","journal":"Neuroscience Applied","publication_date":"2025-12-31","publication_year":2025,"doi":"10.1016/j.nsa.2025.106575","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.106575","keywords":"Neuroscience, Psilocybin, Central nervous system, Chemistry, Medicine, Pharmacology, Hallucinogen, Midbrain, Biology, Neural activity, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-01 06:52:05","last_checked":"2026-07-04 07:00:32","raw_json":"{\"openalex_id\":\"https://openalex.org/W7118002886\",\"openalex_url\":\"https://openalex.org/W7118002886\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121817927\",\"display_name\":\"C. Weber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121758920\",\"display_name\":\"F. Sellitti\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121800044\",\"display_name\":\"L. Ziming\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121803567\",\"display_name\":\"J. von Arx\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121763859\",\"display_name\":\"L.D. Simmler\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106575\",\"is_oa\":true}}","topic_tags":"Pharmacology,Animal Study,Toxicity","study_type":"Animal Study","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W7118002886"},{"id":4475,"title":"Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression","normalized_title":"effects of escitalopram and psilocybin therapy on mesolimbic resting state functional connectivity in depression","authors":"Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris","abstract":"","journal":"Neuroscience Applied","publication_date":"2024-12-31","publication_year":2024,"doi":"10.1016/j.nsa.2025.105421","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.105421","keywords":"Psilocybin, Escitalopram, Functional connectivity, Depression (economics), Psychology, Neuroscience, Hallucinogen, Resting state fMRI, Psychiatry, Antidepressant, Hippocampus, Macroeconomics, Economics, Psychedelics and Drug Studies, Mental Health Research Topics, Biofield Effects and Biophysics","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:41","last_checked":"2026-07-04 07:00:34","raw_json":"{\"openalex_id\":\"https://openalex.org/W4408526135\",\"openalex_url\":\"https://openalex.org/W4408526135\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5110297305\",\"display_name\":\"Rebecca Harding\",\"orcid\":\"https://orcid.org/0009-0008-2701-6930\"},{\"id\":\"https://openalex.org/A5004040027\",\"display_name\":\"Natalie Ertl\",\"orcid\":\"https://orcid.org/0000-0002-9010-1870\"},{\"id\":\"https://openalex.org/A5081484066\",\"display_name\":\"Rabia Zafar\",\"orcid\":\"https://orcid.org/0000-0002-3515-7441\"},{\"id\":\"https://openalex.org/A5109938758\",\"display_name\":\"Magnus Wall\",\"orcid\":null},{\"id\":\"https://openalex.org/A5110486366\",\"display_name\":\"Rajkanya Das\",\"orcid\":\"https://orcid.org/0009-0009-3650-1847\"},{\"id\":\"https://openalex.org/A5044907549\",\"display_name\":\"David Erritzøe\",\"orcid\":\"https://orcid.org/0000-0002-7022-6211\"},{\"id\":\"https://openalex.org/A5101507504\",\"display_name\":\"David Nutt\",\"orcid\":\"https://orcid.org/0000-0002-6423-9411\"},{\"id\":\"https://openalex.org/A5038609897\",\"display_name\":\"Robin Carhart-Harris\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105421\",\"is_oa\":true}}","topic_tags":"Depression,Brain Imaging","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W4408526135"},{"id":4474,"title":"Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior","normalized_title":"long term effects of single dose psilocybin and psychedelic mushroom extract in the sapap3 model of ocd like behavior","authors":"Michal Brownstien","abstract":"","journal":"Neuroscience Applied","publication_date":"2024-12-31","publication_year":2024,"doi":"10.1016/j.nsa.2025.105450","pubmed_id":null,"source_url":"https://doi.org/10.1016/j.nsa.2025.105450","keywords":"Psilocybin, Hallucinogen, Term (time), Psychology, Mushroom, Cognitive psychology, Psychiatry, Chemistry, Physics, Food science, Quantum mechanics, Psychedelics and Drug Studies, Sexuality, Behavior, and Technology, Neurotransmitter Receptor Influence on Behavior","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-04 06:34:41","last_checked":"2026-07-04 07:00:34","raw_json":"{\"openalex_id\":\"https://openalex.org/W4408525624\",\"openalex_url\":\"https://openalex.org/W4408525624\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"contextual-mushroom-match\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5066003352\",\"display_name\":\"Michal Brownstien\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105450\",\"is_oa\":true}}","topic_tags":"OCD,Receptor Pharmacology","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W4408525624"},{"id":769,"title":"Is there room for ethics of authenticity in psilocybin research?","normalized_title":"is there room for ethics of authenticity in psilocybin research","authors":"Stefan Jerotić","abstract":"","journal":"Neuroscience Applied","publication_date":"2024-12-31","publication_year":2024,"doi":"10.1016/j.nsa.2025.105519","pubmed_id":"40654595","source_url":"https://doi.org/10.1016/j.nsa.2025.105519","keywords":"Psilocybin, Psychology, Psychoanalysis, Sociology, Engineering ethics, Hallucinogen, Psychiatry, Engineering, Psychedelics and Drug Studies, Chemical synthesis and alkaloids, Diverse academic research themes","substance_tags":"psilocybin","source_name":"OpenAlex","date_added":"2026-07-01 06:48:04","last_checked":"2026-07-04 07:00:34","raw_json":"{\"openalex_id\":\"https://openalex.org/W4408829649\",\"openalex_url\":\"https://openalex.org/W4408829649\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":2,\"referenced_works\":[\"https://openalex.org/W2118739111\",\"https://openalex.org/W2127389211\",\"https://openalex.org/W2624535799\",\"https://openalex.org/W2759559981\",\"https://openalex.org/W4283211919\",\"https://openalex.org/W4392883849\",\"https://openalex.org/W4400848963\",\"https://openalex.org/W4404933083\",\"https://openalex.org/W6874464476\"],\"authorships\":[{\"id\":\"https://openalex.org/A5069503298\",\"display_name\":\"Stefan Jerotić\",\"orcid\":\"https://orcid.org/0000-0002-7784-0249\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105519\",\"is_oa\":true}}","topic_tags":"General","study_type":"Other","hidden":0,"false_positive":0,"curation_notes":null,"merged_into_id":null,"curation_locked":0,"publication_status":"published","openalex_id":"https://openalex.org/W4408829649"}],"total":59,"page":1,"per_page":20,"pages":3,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Neuroscience Applied","from":null,"to":null,"sort":"newest","page":1,"per_page":"20"}}